Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

18 September 2020: Clinical Research

TNNC1 Reduced Gemcitabine Sensitivity of Nonsmall-Cell Lung Cancer by Increasing Autophagy

Xian Ye ABE , Guanghui Xie D , Zhijian Liu ABCDEFG , Jun Tang F , Mingyuan Cui FG , Chenbin Wang DE , Chi Guo CD , Jianfeng Tang ABC*

DOI: 10.12659/MSM.922703

Med Sci Monit 2020; 26:e922703

Figure 4 Troponin C1, slow skeletal and cardiac type (TNNC1) was negatively regulated by forkhead box 03 (FOXO3). (A) Schematic diagram of the FOXO3 binding sites on the promoter of TNNC1. The expression of TNNC1 in A549 cells transfected with an empty vector (Scramble) or FOXO3 overexpression plasmid (FOXO3-over) was determined by reverse tracscription-quantitative polymerase chain reaction (B, C) or western blot (D). Dual-luciferase reporter assay was used to analyze the TNNC1 promoter activity. The promoter constructs were cotransfected with empty vector (Vector) or FOXO3 overexpression plasmid (FOXO3). (E) Luciferase level was significantly attenuated after the cotransfection of TNNC1 promoter with FOXO3 plasmid compared with the vector plasmid.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750